前往化源商城

伐地那非

更新时间:2024-01-02 12:04:29

伐地那非结构式
伐地那非结构式
品牌特惠专场
常用名 伐地那非 英文名 Vardenafil
CAS号 224785-90-4 分子量 488.60
密度 1.4±0.1 g/cm3 沸点 692.2ºC at 760mmHg
分子式 C23H32N6O4S 熔点 214-216ºC
MSDS N/A 闪点 372.5ºC
符号 GHS02 GHS07
GHS02, GHS07
信号词 Danger

 伐地那非用途


Vardenafil是PDE5抑制剂,可作用于勃起功能障碍。

 伐地那非作用


起效时间快,15至30分钟之内见效。副作用小,但因个体的差异,仍有不足2%的人会略感轻微头痛。溶于水和乙醇的特性,是目前做壮阳酒类、软胶囊及口服液的理想原料,持续时间可达6小时以上。

 伐地那非名称

中文名 盐酸瓦地那非三水合物
英文名 vardenafil
中文别名 伐地那非 | 2-[2-乙氧基-5-(4-乙基-哌嗪-1-磺酰基)苯基]-5-甲基-7-丙基-3H-咪唑[5,1-f]-[1,2,4]三联氮-4-酮单盐酸盐三水合物 | 伐地那非三水合盐酸盐 | 盐酸伐地那非
英文别名 更多

 伐地那非物理化学性质

密度 1.4±0.1 g/cm3
沸点 692.2ºC at 760mmHg
熔点 214-216ºC
分子式 C23H32N6O4S
分子量 488.60
闪点 372.5ºC
PSA 121.28000
LogP 2.65
外观性状 白色结晶粉末
蒸汽压 5.17E-19mmHg at 25°C
折射率 1.656
储存条件 ?20°C

 伐地那非安全信息

符号 GHS02 GHS07
GHS02, GHS07
信号词 Danger
危害声明 H225-H302 + H312 + H332-H319
警示性声明 P210-P261-P302 + P352 + P312-P304 + P340 + P312-P337 + P313-P403 + P235
危害码 (欧洲) F,Xn
风险声明 (欧洲) 11-20/21/22-36
安全声明 (欧洲) 16-36/37
危险品运输编码 UN1230 - class 3 - PG 2 - Methanol, solution

 伐地那非合成线路

~%

伐地那非结构式

伐地那非

224785-90-4

文献:US2007/197535 A1, ; Page/Page column 6 ;

~%

伐地那非结构式

伐地那非

224785-90-4

文献:WO2013/75680 A1, ; Page/Page column 17 ;

~%

伐地那非结构式

伐地那非

224785-90-4

文献:WO2013/75680 A1, ;

 伐地那非上下游产品

伐地那非上游产品  3

伐地那非下游产品  0

 伐地那非文献27

更多文献
Improvement of exercise capacity in monocrotaline-induced pulmonary hypertension by the phosphodiesterase-5 inhibitor Vardenafil.

Respir. Physiol. Neurobiol. 186(1) , 61-4, (2013)

Vardenafil, a phosphodiesterase-5 inhibitor, is approved for the therapy of erectile dysfunction. However, in contrast to Sildenafil and Tadalafil, little is known about its effects on pulmonary hyper...

SOP conservative (medical and mechanical) treatment of erectile dysfunction.

J. Sex. Med. 10(1) , 130-71, (2013)

Erectile dysfunction (ED) is the most frequently treated male sexual dysfunction worldwide. ED is a chronic condition that exerts a negative impact on male self-esteem and nearly all life domains incl...

High inter-individual variability of vardenafil pharmacokinetics in patients with pulmonary hypertension.

Eur. J. Clin. Pharmacol. 69(2) , 197-207, (2013)

To evaluate the pharmacokinetic parameters of a single oral dose of vardenafil in patients with pulmonary hypertension (PH).Sixteen patients with PH received vardenafil in single oral doses (20, 10 or...

 伐地那非英文别名

Vardenafil (INN)
Vivanza
2-{2-Ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one
4-[2-ethoxy-5-(4-ethyl-piperazine-1-sulfonyl)-phenyl]-9-methyl-7-propyl-3,5,6,8-tetrazabicyclo[4.3.0]nona-3,7,9-trien-2-one
Vardenafil hydrochloride trihydrate
[14C]-Vardenafil
2-{2-Ethoxy-5-[(4-ethyl-1-piperazinyl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one
2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-5-methyl-7-propyl-1H-imidazo[5,1-f][1,2,4]triazin-4-one
Vardenafil HCl Trihydrate
4-[2-eyhoxy-5-(4-ethylpiperazin-1-yl)sulfonyl-phenyl]-9-methyl-7-propyl-3,5,6,8-tetrazabicyclo[4,3,0] none 3,7,9 trien-2-one
Imidazo[5,1-f][1,2,4]triazin-4(3H)-one, 2-[2-ethoxy-5-[(4-ethyl-1-piperazinyl)sulfonyl]phenyl]-5-methyl-7-propyl-
vardenafil
Levitra (TN)
品牌现货直购
推荐供应商:





查看所有供应商和价格请点击:

伐地那非生产厂家

伐地那非价格